What drives this global hygiene business?
Ecolab Inc provides water, hygiene, and infection-
Are margins and cash flow holding steady?
FundamentalsFor 2025, reported in USD, revenue was about USD 16.1 billion, with EBIT of roughly USD 2.7 billion and net income of about USD 2.1 billion. Year over year, revenue increased 2.2%, alongside a 44.53% gross margin and a 17.02% operating margin on a trailing basis.
Cash conversion, using the provided proxy that adjusts EBIT for tax, depreciation, and capital spending (and excludes working-capital changes), was about USD 1.9 billion, with depreciation and amortization at USD 673 million and capital spending at USD 1.0 billion. Ecolab ended the period with USD 646.2 million of cash and USD 7.4 billion of total debt. Return on equity over the trailing period was 22.03%.
Is the stock price running ahead of value?
DCF / MultiplesAt USD 270.37 per share, the stock trades above the range implied by the discounted cash flow scenarios provided. The pricing also comes with headline multiples that are not low, including a 36.60 trailing P/E and 24.14 EV/EBITDA.
Execution Risk Dominates at This Price
TakeawayThe price looks demanding relative to the cash-flow valuation. To hold up, returns and margins likely need to stay elevated. If growth stays modest, the valuation can compress quickly. Debt adds less room for operational stumbles. Overall, the setup feels skewed toward execution risk at this price.